Monthly Archives: August 2010
Patient advocate Peg Ford meets with Congresswoman Susan Davis
PATIENT ADVOCATE MEETS WITH CONGRESSWOMAN SUSAN DAVIS PRIOR TO SEPTEMBER “OVARIAN CANCER AWARENESS MONTH” Peg Ford, three and a half year ovarian cancer survivor and patient advocate, met recently with Congresswoman Susan Davis to discuss women’s health issues and her … Continue reading
Posted in Blog Leave a comment
Health Law Requires Continued Coverage For Patients In Clinical Trials
When Richard Crusoe was diagnosed with a rare form of soft tissue cancer called liposarcoma, the retired firefighter and his family pinned their hopes of slowing the cancer’s advance on a drug that was being tested in a clinical trial. … Continue reading
Costco Helps Raise Awareness
The Ovarian Cancer National Alliance would like to thank Costco for educating their shoppers about ovarian cancer this September. All 400+ Costco store locations will be running two of our Public Service Announcements (PSA’s) throughout the month of September on … Continue reading
Posted in Blog Leave a comment
More painkillers needed for cancer patients-experts
Cancer patients, particularly in developing regions, are in dire need of painkillers and affordable drugs, experts said. “It’s shocking and shameful the number of people who suffer needlessly because of the lack of access to analgesics,” John Seffrin, chief executive … Continue reading
Policy Update
Court Ruling on Health Reform In August, a federal judge ruled that the lawsuit filed by Virginia Attorney General Ken Cuccinelli challenging the health reform law can move forward. The suit challenges the constitutionality of the individual mandate — the … Continue reading
Posted in Blog Leave a comment
Avenue opens for new ovarian cancer drugs
New drugs could be developed to hit ovarian cancer with a double blast, scientists have said after identifying a key protein in ‘runaway’ cell division. At present the chemotherapy drug paclitaxel, also known by its brand names Paxol and Abraxane, … Continue reading
Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival.
Purpose: To compare accuracy and interobserver variability in the detection and localization of recurrent ovarian cancer with contrast material-enhanced (CE) computed tomography (CT) and positron emission tomography (PET)/CT and determine whether imaging findings can be used to predict survival. Materials … Continue reading
Report: Cancer Is The World’s Costliest Disease
Cancer is the world’s top “economic killer” as well as its likely leading cause of death, the American Cancer Society contends in a new report it will present at a global cancer conference in China this week. Cancer costs more … Continue reading
